Finerenone has been shown to significantly reduce the risk for cardiovascular death in patients with heart failure in results from the FINEARTS-HF trial.
The medication, finerenone, could be an effective therapy in people with heartfailure who have mildly reduced or preservedejectionfraction, suggests the study, published Sunday in the New ...
Some results have been hidden because they may be inaccessible to you